Swan Ben

Swan Ben agregó una foto Health
2025-09-26 10:04:47 - Translate

New HHS Shakeup Raises Fresh Questions on Ivermectin Research
The U.S. Department of Health and Human Services (HHS) is undergoing a significant restructuring that is reshaping the future of public health, drug research, and regulatory oversight. With HHS reorganization shifting priorities, questions are rising about the future of ivermectin research, oversight of alternative medicine debates, and how broader U.S. health policy is being...

0 Commentarios 0 Acciones 868 Views 0 Vista previa

Please log in to like, share and comment!
Swan Ben agregó una foto Health
2025-09-18 11:28:18 - Translate

Weight Loss Drugs vs. Ivermectin: Driving Up Health Insurance?
The U.S. healthcare system in 2025 is caught in a tug-of-war between two very different medicines: GLP-1 weight loss drugs like Ozempic, and Ivermectin, once famous for its role in the ivermectin covid debates. Today, GLP-1 medications dominate employer health budgets due to skyrocketing demand, while Ivermectin continues to spark heated arguments about fairness,...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Swan Ben agregó una foto Health
2025-09-12 08:30:13 - Translate

MAHA’s Bold Health Plan Triggers Ivermectin Use Speculations
In 2025, the Metropolitan Association of Healthcare Administrators (MAHA) unveiled a comprehensive nationwide healthcare policy blueprint. This ambitious plan, aimed at modernizing U.S. healthcare infrastructure and accessibility, has unexpectedly sparked debates around the potential inclusion of ivermectin as part of broader medical strategies. Experts, policymakers, and the public are...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Swan Ben updated the cover photo
2025-09-12 07:04:45 - Translate

0 Commentarios 0 Acciones 619 Views 0 Vista previa

Please log in to like, share and comment!
Swan Ben updated the profile picture
2025-09-12 06:53:44 - Translate

0 Commentarios 0 Acciones 587 Views 0 Vista previa

Please log in to like, share and comment!